Last updated May 9th 2017
May 7, 2017 | Israeli medical device company CartiHeal has raised $18.3 million in a round of financing led by aMoon, an investment company founded by Check Point Software Technologies Ltd. cofounder Marius Nacht, with participation from previous CartiHeal investors Elron Electronic Industries Ltd. (TASE: ELRN) (the leading investor in CartiHeal), JJDC (the investment fund of Johnson & Johnson), and Peregrine Ventures. CartiHeal is preparing for a human clinical trial of Agili-C, its implant for regenerating damaged cartilage and bone. The company believes that its trial will make it possible to submit its product to the US Food and Drug Administration (FDA) for approval. The trial will take place in the US, Europe, and Israel. CartiHeal has already attained CE marketing approval for Agili-C, but no marketing has actually begun. CEO Nir Altschuler founded CartiHeal in 2009 in cooperation with Ben Gurion University of the Negev.